scholarly article | Q13442814 |
P50 | author | Gniewomir Latacz | Q57909458 |
Katarzyna Kiec-Kononowicz | Q58970601 | ||
Agnieszka Olejarz | Q59691295 | ||
Kamil Kuder | Q81936180 | ||
Tadeusz Karcz | Q117266307 | ||
P2093 | author name string | Holger Stark | |
Ali Saad | |||
Bassem Sadek | |||
P2860 | cites work | ILAE official report: a practical clinical definition of epilepsy | Q27009103 |
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction | Q27860958 | ||
Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy | Q28251042 | ||
Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist | Q28288221 | ||
The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons | Q28292338 | ||
Distinct pharmacology of rat and human histamine H(3) receptors: role of two amino acids in the third transmembrane domain | Q28344970 | ||
Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes | Q29616736 | ||
Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening | Q29617343 | ||
The physiology of brain histamine. | Q31875011 | ||
Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs | Q33756749 | ||
Involvement of central histamine in amygdaloid kindled seizures in rats | Q34097939 | ||
Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs | Q34162438 | ||
Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor | Q34249836 | ||
S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist | Q34250754 | ||
Modifying effects of histamine on circadian rhythms and neuronal excitability | Q34407480 | ||
The histamine H3 receptor: from discovery to clinical trials with pitolisant | Q34629532 | ||
Histamine in the nervous system | Q34795903 | ||
Current use and future potential of organometallic radiopharmaceuticals. | Q34979217 | ||
Bodilisant-a novel fluorescent, highly affine histamine h3 receptor ligand | Q35181936 | ||
Bioorganometallic chemistry of ferrocene | Q35976166 | ||
Luminogenic cytochrome P450 assays | Q36543124 | ||
Histamine H3 receptor antagonists go to clinics | Q37337876 | ||
Several down, a few to go: histamine H3 receptor ligands making the final push towards the market? | Q37944920 | ||
Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives. | Q38023551 | ||
Cherry-picked ligands at histamine receptor subtypes. | Q38637712 | ||
Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases | Q38882359 | ||
Aryl-1,3,5-triazine derivatives as histamine H4 receptor ligands. | Q38977969 | ||
The study of cellular cytotoxicity of argireline - an anti-aging peptide | Q39014003 | ||
Effects of antihistamines on the function of human α7-nicotinic acetylcholine receptors. | Q39090568 | ||
Anticonvulsant properties of histamine H3 receptor ligands belonging to N-substituted carbamates of imidazopropanol | Q39377196 | ||
Kojic acid derivatives as histamine H(3) receptor ligands | Q39647030 | ||
Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonists | Q40318984 | ||
Seizure susceptibility due to antihistamines in febrile seizures | Q40363396 | ||
Histamine in cerebrospinal fluid of children with febrile convulsions | Q40688399 | ||
Is histamine an anticonvulsive inhibitory transmitter? | Q42059596 | ||
Comparative anticonvulsant activity and neurotoxicity of felbamate and four prototype antiepileptic drugs in mice and rats | Q42205553 | ||
Drug-likeness approach of 2-aminopyrimidines as histamine H3 receptor ligands. | Q42921406 | ||
Levetiracetam in submaximal subcutaneous pentylentetrazol-induced seizures in rats | Q43095470 | ||
The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models | Q43464905 | ||
Influence of imidazole replacement in different structural classes of histamine H(3)-receptor antagonists | Q43625285 | ||
Sensitive radioimmunoassays for histamine and tele-methylhistamine in the brain | Q44298077 | ||
Efficacy of the histamine 3 receptor (H3R) antagonist pitolisant (formerly known as tiprolisant; BF2.649) in epilepsy: dose-dependent effects in the human photosensitivity model | Q44449222 | ||
Effects of endogenous histamine on seizure development of pentylenetetrazole-induced kindling in rats. | Q44529329 | ||
Development of amygdaloid kindling in histidine decarboxylase-deficient and histamine H1 receptor-deficient mice | Q44805056 | ||
Role of histaminergic neurons in development of epileptic seizures in EL mice | Q45153402 | ||
Fluorinated non-imidazole histamine H3 receptor antagonists | Q46088221 | ||
Fancy bioisosteres: metallocene-derived G-protein-coupled receptor ligands with subnanomolar binding affinity and novel selectivity profiles | Q46509579 | ||
MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist | Q46775772 | ||
Anticonvulsant activity of the methanolic extract of Justicia extensa T. Anders | Q47257639 | ||
Chlorophenoxy aminoalkyl derivatives as histamine H(3)R ligands and antiseizure agents. | Q47934602 | ||
Anticonvulsant, neuroprotective and behavioral effects of organic and conventional yerba mate (Ilex paraguariensis St. Hil.) on pentylenetetrazol-induced seizures in Wistar rats | Q48238572 | ||
Dual localization of histamine in an ascending neuronal pathway and in non-neuronal cells evidenced by lesions in the lateral hypothalamic area | Q48392299 | ||
The effects of histamine H3-receptor antagonists on amygdaloid kindled seizures in rats | Q48395108 | ||
Histaminergic mechanisms in amygdaloid-kindled seizures in rats | Q48433993 | ||
Mechanism of imipramine-induced seizures in amygdala-kindled rats | Q48445673 | ||
Effects of alpha-fluoromethylhistidine on locomotor activity, brain histamine and catecholamine contents in rats | Q48512875 | ||
Pentylenetetrazol-induced kindling in rats: Effect of GABA function inhibitors | Q48646145 | ||
Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats. | Q50551591 | ||
The novel non-imidazole histamine H3 receptor antagonist DL77 reduces voluntary alcohol intake and ethanol-induced conditioned place preference in mice. | Q50578120 | ||
Anticonvulsive effect of nonimidazole histamine H3 receptor antagonists. | Q51091396 | ||
(2-Arylethenyl)-1,3,5-triazin-2-amines as a novel histamine H4 receptor ligands. | Q51334897 | ||
Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties. | Q51749619 | ||
The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models | Q67994775 | ||
[125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors | Q72818403 | ||
Planar chromatography | Q74386385 | ||
Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligands | Q79956903 | ||
Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands | Q83211003 | ||
Seizure-modifying potential of histamine H1 antagonists: a clinical observation | Q83284712 | ||
Characterization of anticonvulsant and antiepileptogenic potential of thymol in various experimental models | Q86033464 | ||
Characterization of a lamotrigine-resistant kindled model of epilepsy in mice: evaluation of drug resistance mechanisms | Q87535408 | ||
Commentary: Consciousness of epilepsy | Q95420094 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | seizure | Q6279182 |
P304 | page(s) | 3879-3898 | |
P577 | publication date | 2016-11-25 | |
P1433 | published in | Drug Design, Development and Therapy | Q2566724 |
P1476 | title | Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats | |
P478 | volume | 10 |
Q49167073 | Anticonvulsant and reproductive toxicological studies of the imidazole-based histamine H3R antagonist 2-18 in mice. |
Q48316817 | Anticonvulsant effect of sodium cyclamate and propylparaben on pentylenetetrazol-induced seizures in zebrafish. |
Q89729736 | Betahistine, prevents kindling, ameliorates the behavioral comorbidities and neurodegeneration induced by pentylenetetrazole |
Q47833839 | In the search for a lead structure among series of potent and selective hydantoin 5-HT7 R agents: The drug-likeness in vitro study. |
Q90399887 | Influence of the Novel Histamine H3 Receptor Antagonist/Inverse Agonist M39 on Gastroprotection and PGE2 Production Induced by (R)-Alpha-Methylhistamine in C57BL/6 Mice |
Q96953395 | Role of Neuroinflammation in Autism Spectrum Disorder and the Emergence of Brain Histaminergic System. Lessons Also for BPSD? |
Q47239447 | Selenazolinium Salts as "Small Molecule Catalysts" with High Potency against ESKAPE Bacterial Pathogens. |
Q58103536 | Studies on Anticonvulsant Effects of Novel Histamine H3R Antagonists in Electrically and Chemically Induced Seizures in Rats |
Q47996823 | Study on the effect of EMD386088, a 5-HT6 receptor partial agonist, in enhancing the anti-immobility action of some antidepressants in rats. |
Q42691812 | The Histamine H3 Receptor Antagonist E159 Reverses Memory Deficits Induced by Dizocilpine in Passive Avoidance and Novel Object Recognition Paradigm in Rats |
Search more.